British drug maker AstraZeneca Plc (AZN.L, AZN) announced Tuesday positive data from global KOMET Phase III trial, in which Koselugo ...

AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...

High-level results of KOMET, the largest, global randomised double-blind placebo-controlled multicentre Phase III trial in adults with ...

KOMET phase III trial of Koselugo shows statistically significant and clinically meaningful ORR vs. placebo in adults with neurofibromatosis type 1: Cambridge, UK Wednesday, Novem ...

7 Stroke Warning Signs 1 Month Before It Happens 2024 | Stroke Signs and Symptoms Video AstraZeneca backs US and China - but ...

The Ukrainian 95th airborne assault brigade released drone footage on Monday said to show strikes on Russian troops in Kursk ...

More than one in two Irish parents say their child missed schools days in the past year due to flu or flu-like symptoms with ...

More than 400 million people currently suffer from some type of diabetes, a figure that represents 1 in 11 adults worldwide ...

In May 2024, GSK announced positive headline results from the phase III clinical trials SWIFT-1 and SWIFT-2, which assessed the efficacy and safety of depemokimab versus placebo in adults and ...

In-licensed ALXN-1840 (a Late-Stage Wilson Disease Drug Candidate) from Alexion, AstraZeneca Rare DiseaseTwo Novel Radiopharma Clinical Trials now Active and Enrolling Patients with Advanced Solid Can ...

AstraZeneca continues to lead development and Amgen continues ... Prevalence of sinonasal outcome test (SNOT-22) symptoms in ...

help to make World Diabetes Day a global success by providing valuable support for the development of campaign resources and ...